Stay updated on Oncolytics Biotech Press Releases
Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.

Latest updates to the Oncolytics Biotech Press Releases page
- Check4 days agoChange DetectedThe investor stock quote block now displays a current price of $0.75 with a daily percentage change of 0.00%. This replaces the prior quote of $0.81 and a -4.25% daily change.SummaryDifference0.8%

- Check11 days agoChange DetectedThe investor page now displays the latest NASD:ONCY stock figures and adds a Fast Track designation press release; an older stock quote and a governance-related appointment announcement were removed.SummaryDifference3%

- Check18 days agoChange DetectedThe stock quote on the Investor Overview page is updated to $0.85 with a -0.03 change and -3.40%, replacing the previous $0.89, -0.033, -3.59% figures. A new press release headline about FDA regulatory milestone and strong clinical progress in a randomized RAS-mutant MSS colorectal cancer trial was added, and the June 1, 2026 press release listing was removed.SummaryDifference3%

- Check25 days agoChange DetectedRepresents updated intraday stock data on the Investor Overview page, showing the current price of $0.89 and a daily decline of -$0.033 (-3.59%). This replaces the previous price of $0.90 and -$0.002 (-0.22%).SummaryDifference0.8%

- Check32 days agoChange DetectedThe stock quote on the investor page now shows a current price of $0.90 with a daily change of -0.002 (-0.22%). The previous quote was $0.95 with -0.028 (-3.04%).SummaryDifference0.8%

- Check39 days agoChange DetectedInvestor quote updated to $0.95 and 3.04%, replacing the previous $0.96 and 3.00%.SummaryDifference0.6%

Stay in the know with updates to Oncolytics Biotech Press Releases
Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.